J&j Innovative Medicine recalls IMAAVY (nipocalimab-aahu) Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- What's wrong
- Presence of particulate matter.
- Products
-
- IMAAVY (nipocalimab-aahu) Injection
- Company
- J&j Innovative Medicine
- Where it was sold
-
OH
States: Ohio
- Units affected
- 49 vials
- Status
- Ongoing
Recall Relay is not affiliated with or endorsed by FDA or any agency. Details here are copied from the FDA notice and may lag behind it; the official notice is always the final word.